Keyphrases
Peru
100%
Lima
100%
Antiretroviral Therapy
100%
HIV Drug Resistance
100%
First-line Antiretroviral Therapy
100%
Drug-resistant HIV
50%
Virological Failure
37%
Antiretroviral
25%
Oligonucleotide Ligation Assay
25%
Codon
25%
Y181C
25%
Peruvian
12%
Polymorphism
12%
Peripheral Blood Mononuclear Cells
12%
HIV Patients
12%
Low Prevalence
12%
Nevirapine
12%
Drug Resistance mutations
12%
M184V
12%
Antiretroviral Resistance
12%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
12%
Reverse Transcriptase
12%
Therapeutic Program
12%
K103N
12%
HIV Viral Load
12%
Antiretroviral Naïve
12%
Level Reduction
12%
High-level Resistance
12%
Viral Replication
12%
Longitudinal Observational Study
12%
Blood Cells
12%
Antiretroviral Therapy Initiation
12%
Blood Plasma
12%
Medicine and Dentistry
Antiretroviral Therapy
100%
HIV Resistance
100%
Human Immunodeficiency Virus
60%
Prevalence
20%
Oligonucleotide
20%
Ligation
20%
Codon
20%
Observational Study
10%
Drug Resistance
10%
Peripheral Blood Mononuclear Cell
10%
Nevirapine
10%
Resistance Mutation
10%
RNA Directed DNA Polymerase
10%
Nonnucleoside Reverse Transcriptase Inhibitor
10%
Blood Plasma
10%
Virus Replication
10%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Blood Plasma
42%
Prevalence
28%
Reverse Transcriptase
28%
Codon
28%
Viral Replication
14%
CD4
14%
Drug Resistance
14%
Peripheral Blood Mononuclear Cell
14%
Neuroscience
Human Immunodeficiency Virus
100%
Blood Plasma
42%
Codon
28%
Oligonucleotide
28%
Peripheral Blood Mononuclear Cell
14%
Drug Resistance
14%
CD4
14%
Reverse Transcriptase
14%
Reverse-Transcriptase Inhibitor
14%
Nevirapine
14%